First Manhattan’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3
| Closed | -$39 | – | 1410 |
|
|
2024
Q1 | $39 | Hold |
3
| – | – | ﹤0.01% | 1400 |
|
|
2023
Q4 | $45 | Hold |
3
| – | – | ﹤0.01% | 1424 |
|
|
2023
Q3 | $44 | Hold |
3
| – | – | ﹤0.01% | 1474 |
|
|
2023
Q2 | $39 | Hold |
3
| – | – | ﹤0.01% | 1412 |
|
|
2023
Q1 | $29 | Hold |
3
| – | – | ﹤0.01% | 1505 |
|
|
2022
Q4 | $38 | Hold |
3
| – | – | ﹤0.01% | 1661 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1710 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1715 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1731 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1725 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1723 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1656 |
|
|
2021
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1589 |
|